￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Erlotinib prolongs patient survival by up to 11 months!

2025-10-19 11:44:20

Check Details
The third generation of EGFR-targeted drugs, a detailed explanation of osimertinib in one article

2025-10-19 11:44:20

Check Details
Compared with previous generation drugs, dacomitinib extends the survival period by more than half!

2025-10-19 11:44:20

Check Details
Compared with the previous generation of drugs, afatinib has more significant efficacy_ Kanghule

2025-10-19 11:44:20

Check Details
Tepotinib is approved for marketing in China, which is of great significance

2025-10-19 11:44:20

Check Details
How to solve the problem of hyperlipidemia in patients taking lorlatinib?

2025-10-19 11:44:20

Check Details
The third generation ALK inhibitor, how good is lorlatinib? _ Kanghule

2025-10-19 11:44:20

Check Details
A potential stock for multi-faceted cancer killing—ramucirumab

2025-10-19 11:44:20

Check Details
How effective is cabozantinib in treating renal cancer?

2025-10-19 11:44:20

Check Details
What kind of drug is gefitinib? What are the adverse reactions of gefitinib?

2025-10-19 11:44:20

Check Details
How effective is erlotinib in treating non-small cell lung cancer?

2025-10-19 11:44:20

Check Details
What are the differences between afatinib and the first-generation drug gefitinib?

2025-10-19 11:44:20

Check Details
Category
相关知识